The Future of Basal Insulin

The Future of Basal Insulin: Improving Patient Outcomes by Addressing Unmet Needs

AAFP Accreditation Statement:

This enduring material activity, CME Report: The Future of Basal Insulin: Improving Patient Outcomes by Addressing Unmet Needs, has been reviewed and is acceptable for up to 2 Prescribed credits by the American Academy of Family Physicians. AAFP certification begins [09/01/15]. Term of approval is for one year from this date with the option of yearly renewal. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Relevant Financial Relationships:

In accordance with the ACCME Standards for Commercial Support and with the policies of the American Academy of Family Physicians, NJAFP policy require that all persons that affect the content of this CME activity disclose to the CME providers financial relationships they or their spouse/significant other have with either the commercial supporter of this activity or with the manufacturers of any products they are referencing in this enduring material. The following individuals have provided disclosure information:

Reviewer:

The reviewer for this activity has disclosed no relevant financial relationships.

Acknowledgement of Commercial Support:

This program is supported by an educational grant from sanofi-aventis U.S.

Date of Release and Termination Date:

The Date of Release for this activity is:  09/01/15

The Terminate Date for this activity is: 08/31/16

Process to Complete and Claim Credit for This Activity:

To receive credit for this activity, learners must (1) read the entire article, (2) complete the evaluation and post-test, and (3) claim the number of credits earned up to the maximum allowed for the activity. Certificates for credit claimed will be provided to learners after completion of the post-test and evaluation

General Objective: 

To enable primary care clinicians to use basal insulin in the management of type 2 diabetes. 

Acknowledgments:

The New Jersey Academy of Family Physicians developed this program. The Academy wishes to thank medical writer Charles A. Goldthwaite, Jr., PhD, project manager Jack Douglass, and graphic designer Karl Benner for their efforts in producing this material.

Target Audience

Family Physicians and other primary care physicians

Learning Objectives

Specific Objectives:
At the end of this program, participants will be able to:

  • Recognize patients who should receive basal insulin.
  • ​Employ strategies to overcome barriers that traditionally inhibit the initiation of insulin.
  • Identify gaps in care for patients with type 2 diabetes who are being treated with basal insulin.
  • Differentiate between traditional basal insulin formulations and newly-approved/developmental formulations.
  • Integrate basal insulin into a patient-centered type 2 diabetes management plan.

Additional Information

Course summary
Available credit: 
  • 1.00 AAFP Prescribed
  • 1.00 Attendance
Course opens: 
09/01/2015
Course expires: 
08/31/2016
Rating: 
5

Planners:

Name

Manufacturer with whom there is a Financial Relationship

Type of Relationship

Theresa Barrett, PhD

NA

No Relationships

Jack Douglass

NA

No Relationships

Charles A. Goldthwaite, Jr., PhD

NA

No Relationships

Authors:

Name

Manufacturer with whom there is a Financial Relationship

Type of Relationship

Intekhab Ahmed, MD, FACE, FACP

Novo Nordisk

Boehringer Ingelheim

AstraZeneca

sanofi-aventis

Paid Consultant

Robert Gorman, MD, FAAFP

NA

No Relationships

Marc Sandberg, MD, FACP, CDE

Eli Lilly and Company

Novo Nordisk

Valeritas, Inc.

Boehringer Ingelheim

AstraZeneca

Speakers Bureau

Penny Tenzer, MD, FAAFP

NA

No Relationships

Faculty

Intekhab Ahmed, MD, FACE, FACP
Professor of Medicine, Program Director for Endocrine Fellowship, Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, PA

Robert Gorman, MD, FAAFP
Chairman, Department of Family Medicine, Hackensack UMC Mountainside Hospital, Assistant Clinical Professor of Family Medicine, Rutgers New Jersey Medical School, Verona, NJ

Marc Sandberg, MD, FACP, CDE
Medical Director, Center for Nutritional and Diabetes Management and the, Diabetes and Endocrine Associates of Hunterdon, Hunterdon Medical Center, Flemington, NJ; Clinical Assistant Professor, Department of Medicine Temple University School of Medicine, Philadelphia, PA

Penny Tenzer, MD, FAAFP
Professor of Clinical Family Medicine, Vice Chair of Academic Affairs, Department of Family Medicine & Community Health, Chief of Service, Family Medicine, University of Miami Hospital, University of Miami Miller School of Medicine, Miami, FL

Available Credit

  • 1.00 AAFP Prescribed
  • 1.00 Attendance

Accreditation Period

Course opens: 
09/01/2015
Course expires: 
08/31/2016
Please login or register to take this course.